Montelukast%252525252525252520levocetrizine

# Montelukast and Levocetirizine ## Overview This combination involves a selective leukotriene receptor antagonist (montelukast) and a second-generation H1-receptor antagonist (levocetirizine). They are often prescribed together for chronic allergic rhinitis and urticaria to provide synergistic control of inflammatory mediators (leukotrienes and histamine). ## Primary Indications - Seasonal or perennial allergic rhinitis. - Chronic idiopathic urticaria. - Off-label: Adjunct for refractory vasomotor rhinitis or generalized pruritus. ## Adult Dosing - **Montelukast:** 10 mg orally once daily, preferably in the evening. - **Levocetirizine:** 5 mg orally once daily, preferably in the evening. ## Pediatric Dosing *Note: Dosages vary by age; consult specific product labeling.* - **Montelukast:** - 6–14 years: 5 mg (chewable) daily. - 6 months–5 years: 4 mg (oral granules or chewable) daily. - **Levocetirizine:** - 6–11 years: 2.5 mg daily. - 12+ years: 5 mg daily. ## Dose Adjustments - **Renal Impairment (Levocetirizine):** Must be dose-adjusted based on CrCl. - CrCl 50–80 mL/min: 2.5 mg daily. - CrCl 30–50 mL/min: 2.5 mg every 48 hours. - CrCl <30 mL/min: Use contraindicated or adjust per specialized nephrology protocol. - **Hepatic Impairment:** No standard adjustment for montelukast; use caution. ## Contraindications - **Montelukast:** Known hypersensitivity to the drug. - **Levocetirizine:** End-stage renal disease (CrCl <10 mL/min) and hemodialysis; hypersensitivity to cetirizine or hydroxyzine. ## Adverse Effects - **Montelukast:** Neuropsychiatric events (agitation, depression, sleep disturbances, suicidal ideation - FDA Black Box Warning), headache, abdominal pain. - **Levocetirizine:** Somnolence, fatigue, nasopharyngitis, dry mouth. ## Key Drug Interactions - **Montelukast:** Potential interaction with strong CYP2C8 inhibitors (e.g., gemfibrozil) which may increase montelukast exposure. - **Levocetirizine:** Additive CNS depression with alcohol, sedatives, or other antihistamines. ## Monitoring - **Neuropsychiatric:** Monitor for baseline and emergent changes in mood, behavior, or sleep patterns (Montelukast). - **Renal:** Periodically assess renal function in patients taking levocetirizine, especially the elderly. - **Efficacy:** Assess symptoms (nasal congestion, sneezing, itching) at 2–4 week intervals. ## Clinical Pearls - **Timing:** Both medications are best taken in the evening to counteract peak symptom times and provide sleep-independent sedation (for levocetirizine). - **Safety Signal:** Due to the risk of serious neuropsychiatric events, montelukast should be reserved for cases where other treatments are inadequate or not tolerated. - **Granules:** Montelukast oral granules may be placed directly on the tongue or mixed with a spoonful of cold/room-temperature soft food; must be consumed within 15 minutes. *** **Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines vary by institution and region. Always consult the most current FDA-approved prescribing information, local formulary protocols, and clinical pharmacology databases (e.g., UpToDate, Lexicomp) before prescribing or administering these medications.